US Regulator Approves Pfizer's RSV Vaccine for Adults 60 and Older

The U.S. Food and Drug Administration (FDA) on Wednesday approved Pfizer Inc.'s respiratory syncytial virus (RSV) vaccine for older adults, making it the second ... Read more

Bron:

Economy - Voice of America